日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Clinical Outcomes of Adults Hospitalized for COVID-19 Pneumonia

新冠肺炎住院成年患者的长期临床结局

Rosas, Ivan O; Benitez, Alejandra; McKinnell, James A; Shah, Reena; Waters, Michael; Hunter, Bradley D; Jeanfreau, Robert; Tsai, Larry; Neighbors, Margaret; Trzaskoma, Ben; de Cassia Castro, Rita; Cai, Fang

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

研究性呼吸道合胞病毒疫苗(RSVPreF3)在母亲及其婴儿中的安全性和免疫原性:一项 2 期随机试验

Bebia, Zourab; Reyes, Osvaldo; Jeanfreau, Robert; Kantele, Anu; De Leon, Ruth Graciela; Sánchez, Marta García; Banooni, Peyman; Gardener, Glenn J; Rasero, José Luis Bartha; Pardilla, Maria Begoña Encinas; Langley, Joanne M; Di Leo, Claudio Maañón; Botelho-Nevers, Elisabeth; Buttery, Jim; Laurichesse, Helene; Madhi, Shabir A; García, Adrián Martín; Stanley, Thorsten; Barjat, Tiphaine; Griffith, Rebecca; Castrejón-Alba, Maria Mercedes; de Heusch, Magali; Dieussaert, Ilse; Hercor, Melanie; Lese, Patricia; Qian, Hui; Tullio, Antonella N; Henry, Ouzama

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

NVX-CoV2373 在美国和墨西哥成年人中的疗效和安全性

Dunkle, Lisa M; Kotloff, Karen L; Gay, Cynthia L; Áñez, Germán; Adelglass, Jeffrey M; Barrat Hernández, Alejandro Q; Harper, Wayne L; Duncanson, Daniel M; McArthur, Monica A; Florescu, Diana F; McClelland, R Scott; Garcia-Fragoso, Veronica; Riesenberg, Robert A; Musante, David B; Fried, David L; Safirstein, Beth E; McKenzie, Mark; Jeanfreau, Robert J; Kingsley, Jeffrey K; Henderson, Jeffrey A; Lane, Dakotah C; Ruíz-Palacios, Guillermo M; Corey, Lawrence; Neuzil, Kathleen M; Coombs, Robert W; Greninger, Alex L; Hutter, Julia; Ake, Julie A; Smith, Katherine; Woo, Wayne; Cho, Iksung; Glenn, Gregory M; Dubovsky, Filip

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial

抗粒细胞-巨噬细胞集落刺激因子单克隆抗体吉姆西鲁单抗治疗COVID-19肺炎:一项随机、双盲、安慰剂对照试验

Criner, Gerard J; Lang, Frederick M; Gottlieb, Robert L; Mathews, Kusum S; Wang, Tisha S; Rice, Todd W; Madduri, Deepu; Bellam, Shashi; Jeanfreau, Robert; Case, Amy H; Glassberg, Marilyn K; Lyon, George Marshall; Ahmad, Kareem; Mendelson, Robert; DiMaio, J Michael; Tran, MaryAnn P; Spak, Cedric W; Abbasi, Jamil A; Davis, Steven G; Ghamande, Shekhar; Shen, Steven; Sherman, Lisa; Lowry, Simon

Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study

四价脑膜炎球菌破伤风类毒素结合疫苗(MenACYW-TT)加强剂在青少年和成人中的免疫原性和安全性:一项III期随机研究

Áñez, Germán; Hedrick, James; Simon, Michael W; Christensen, Shane; Jeanfreau, Robert; Yau, Eddy; Pan, Judy; Jordanov, Emilia; Dhingra, Mandeep S

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial

全剂量裂解病毒灭活四价流感疫苗在6-35个月龄健康儿童中的安全性和免疫原性:一项随机对照临床试验

Robertson, Corwin A; Mercer, Monica; Selmani, Alexandre; Klein, Nicola P; Jeanfreau, Robert; Greenberg, David P

Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial

是时候改变幼儿四价灭活流感疫苗的剂量了:一项 III 期随机对照试验的证据

Jain, Varsha K; Domachowske, Joseph B; Wang, Long; Ofori-Anyinam, Opokua; Rodríguez-Weber, Miguel A; Leonardi, Michael L; Klein, Nicola P; Schlichter, Gary; Jeanfreau, Robert; Haney, Byron L; Chu, Laurence; Harris, Jo-Ann S; Sarpong, Kwabena O; Micucio, Amanda C; Soni, Jyoti; Chandrasekaran, Vijayalakshmi; Li, Ping; Innis, Bruce L

AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial

AS03B佐剂H5N1流感疫苗在6个月至17岁儿童中的应用:一项2/3期随机、安慰剂对照、观察者盲法试验

Kosalaraksa, Pope; Jeanfreau, Robert; Frenette, Louise; Drame, Mamadou; Madariaga, Miguel; Innis, Bruce L; Godeaux, Olivier; Izurieta, Patricia; Vaughn, David W

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months

美国12-15个月龄儿童接种不含人血清白蛋白的麻疹、腮腺炎、风疹疫苗的安全性和免疫原性

Mufson, Maurice A; Diaz, Clemente; Leonardi, Michael; Harrison, Christopher J; Grogg, Stanley; Carbayo, Antonio; Carlo-Torres, Simon; JeanFreau, Robert; Quintero-Del-Rio, Ana; Bautista, Gisele; Povey, Michael; Da Costa, Christopher; Nicholson, Ouzama; Innis, Bruce L

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

一项随机对照研究,旨在评估两种剂量的三价灭活季节性流感疫苗在6至35个月龄儿童中的免疫原性。

Pavia-Ruz, Noris; Angel Rodriguez Weber, Miguel; Lau, Yu-Lung; Nelson, E Anthony S; Kerdpanich, Angkool; Huang, Li-Min; Silas, Peter; Qaqundah, Paul; Blatter, Mark; Jeanfreau, Robert; Lei, Paul; Jain, Varsha; El Idrissi, Mohamed; Feng, Yang; Innis, Bruce; Peeters, Mathieu; Devaster, Jeanne-Marie